| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $673.8M | -9.1% |
| Cost of Revenue | $477.8M | -2.8% |
| Gross Profit | $195.9M | -21.4% |
| R&D Expense | $81.1M | -2.7% |
| SG&A Expense | $63.5M | -4.2% |
| Operating Income | $12.2M | +136.7% |
| Pre-tax Income | $24.9M | +230.1% |
| Income Tax | $12.5M | -85.4% |
| Net Income | $12.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $286.4M | +62.1% |
| Short-term Investments | $122.2M | +14.3% |
| Accounts Receivable | $156.2M | -15.6% |
| Inventory | $162.5M | -34.7% |
| Current Assets | $758.0M | +1.3% |
| Total Assets | $850.2M | +0.4% |
| Current Liabilities | $270.1M | +2.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $164.8M | +189.9% |
| Capital Expenditures | $9.0M | +55.1% |
| Investing Cash Flow | -$26.2M | +4.7% |
| Financing Cash Flow | -$28.9M | -3727.7% |
| Free Cash Flow | $155.8M | +205.2% |
| +111.8% |
| EPS (Basic) | $0.43 | +112.0% |
| EPS (Diluted) | $0.42 | +111.8% |
| Total Liabilities |
| $309.2M |
| -0.8% |
| Stockholders' Equity | $541.1M | +1.0% |